The FDA on November 1, 2013 approved GAZYVA® for use in combination with Chlorambucil (LEUKERAN®), for the treatment of patients with previously untreated Chronic Lymphocytic Leukemia (CLL). GAZYVA® is an injection, for intravenous use and is a product of Genentech, Inc.
Bottom Ad
Advertisement
Subscribe
